Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06715735 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HAPA-based Intervention in Adults With Metabolic Syndrome and Chronic Kidney Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Interventions modified Eligibility criteria expanded, about 11 words · Secondary endpoints: 5 to 9 · Study description expanded, about 61 words · 1 more Show 4 more changesShow less
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: 5 to 9
    • Study description expanded, about 61 words
    • Study title shortened, about 3 words
  2. Notable Trial status: Active, Not Recruiting to Recruiting Primary and study completion dates: Jun 30, 2026 to Oct 30, 2026 · Eligibility criteria shortened, about 16 words · Study description shortened, about 9 words · 1 morev3 Show 4 more changesShow less
    • Primary and study completion dates: Jun 30, 2026 to Oct 30, 2026
    • Eligibility criteria shortened, about 16 words
    • Study description shortened, about 9 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  3. Minor Trial status: Not Yet Recruiting to Active, Not Recruiting Site contact updated · Study title revisedv2 Show 2 more changesShow less
    • Site contact updated
    • Study title revised

    See this version in full on ClinicalTrials.gov ↗

  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will adopt a 2-arm, pretest-posttest, and assessor-blind RCT design to examine the effectiveness of a theory-based health behaviour change intervention on WC (primary outcome), kidney function (eGFR, primary outcome), dietary behaviour, PA, exercise capacity, and self-efficacy of dietary behaviour and PA among Chinese adults with metabolic syndrome and chronic kidney disease. A total of 160 adults with metabolic syndrome and chronic kidney disease will be recruited, with 80 participants in each group. Data will be collected at 4 time points (baseline, immediate post-intervention, 1-month post-intervention, and 6-month post-intervention) via an online questionnaire survey platform (Qualtrics) by researchers blinded to the group allocation to reduce the detection bias.
Trial Details
NCT Number NCT06715735
Lead Sponsor Chinese University of Hong Kong
Conditions Chronic Kidney Diseases, Metabolic Syndrome
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov